首页> 外文OA文献 >One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease.

【2h】

One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease.

机译：一年的酶替代疗法减少法布里病患者的足细胞中的球蛋白神经酰胺包含物。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

AI期刊论文写作 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Behzad Najafian; Camilla Tøndel; Einar Svarstad; Alexey Sokolovkiy; Kelly Smith; Michael Mauer;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Enzyme replacement therapy in Fabry disease reduces podocyte globotriaosylceramide (GL3) content within a year [J] . Najaflan Behzad, Mauer Michael Molecular genetics and metabolism . 2015,第2期

机译：Fabry病中的酶替代疗法可在一年内降低足细胞globotriaosylceramide（GL3）的含量
2. Podocyte globotriaosylceramide (GL-3) content in male adult patients with Fabry disease reduces following 6-12 months of treatment with migalastat [J] . Najafian Behzad, Sokolovskiy Alexey, Barth Jay, Molecular genetics and metabolism . 2016,第2期

机译：接受migalastat治疗的6至12个月后，患有法布里（Fabry）病的男性成年患者的足细胞globotriaosylceramide（GL-3）含量降低
3. Massive accumulation of globotriaosylceramide in various tissues from a Fabry patient with a high antibody titer against alpha-galactosidase A after 6?years of enzyme replacement therapy [J] . Kenichi Hongo, Toru Harada, Eiko Fukuro, Molecular Genetics and Metabolism Reports . 2020,第1期

机译：用高抗体滴度与α-半乳糖苷酶A患者在6岁的酶替代疗法后，在来自法布里患者的各种组织中的巨大累积
4. Endothelial Targeted Enzyme Replacement Therapy for Fabry Disease [C] . D. Serrano, J. Hsu, K.V.N. Kumar, Annual meeting exposition of the Controlled Release Society . 2009

机译：Fabry病的内皮靶向酶替代治疗
5. The power of art: Using art therapy to minimize agitation: A case study of an adult male with Alzheimer's disease. [D] . Vetter, Jennifer M. 2007

机译：艺术的力量：使用艺术疗法最大程度地减少躁动：一名患有阿尔茨海默氏病的成年男性的案例研究。
6. One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease [O] . Behzad Najafian, Camilla Tøndel, Einar Svarstad, -1

机译：一年的酶替代疗法减少了成年法布里病成年男性患者足细胞中的globotriaosylceramide包裹物
7. MO127CLEARED PODOCYTES AND NORMAL KIDNEY FUNCTION IN CLASSICAL FABRY MALES 15 YEARS AFTER START OF ENZYME REPLACEMENT THERAPY AT YOUNG AGE* [O] . Camilla Tøndel, Idunn Riisnes, Sabine Leh, 2021

机译：MO127核心肾小序细胞和正常的肾功能在古典法布里男性在年轻时开始酶替代治疗后15年*
8. Pilot Scale Isolation of Ceramide Trihexosidase from Human Plasma and Clinical Evaluation of Enzyme Replacement Therapy in Fabry's Disease. [R] . sweeley,charles c. 1975

机译：人体血浆中神经酰胺三己糖苷酶的中试分离及法布里氏病酶替代疗法的临床评价。

One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease.

著录项

引文网络

相似文献

相关主题

期刊订阅